Nurse Practitioner · Dalton, GA
NPI
1295893204
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1107 Memorial Dr, Suite 201
Dalton, GA, 30720
Phone (706) 277-7311
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
5,384 services
Medicare patients, 2024
916
Average age 75
Drug cost, 2024
$3.0M
1,666 prescriptions
Company payments, 2025
$154K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor Czerkasij was code 17003 (destruction skin lesion), 2,462 times for 391 patients. In total Victor Czerkasij billed 5,384 services in 27 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,462 | 391 | $3.75 | $9,227 |
| 17000 Destruction Skin Lesion | Office | 716 | 517 | $31.40 | $22K |
| 99213 Office E&M - Established | Office | 603 | 485 | $49.05 | $30K |
| 99212 Office E&M - Established | Office | 347 | 313 | $28.26 | $9,806 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 338 | 46 | $0.68 | $231 |
| 11102 Skin Biopsy | Office | 283 | 251 | $53.21 | $15K |
| 99214 Office E&M - Established | Office | 155 | 138 | $75.72 | $12K |
| 17110 Destruction Skin Lesion | Office | 121 | 114 | $62.63 | $7,578 |
| 17004 Destruction Skin Lesion | Office | 93 | 65 | $90.32 | $8,399 |
| 96372 Injection Administration | Office | 63 | 42 | $7.82 | $493 |
| 11103 Skin Biopsy | Office | 56 | 44 | $28.74 | $1,609 |
| 99203 Office E&M - New | Office | 48 | 48 | $62.26 | $2,988 |
| 99202 Office E&M - New | Office | 31 | 31 | $29.48 | $914 |
| 99204 Office E&M - New | Office | 19 | 19 | $90.80 | $1,725 |
| 11900 Skin | Office | 13 | 12 | $18.77 | $244 |
By year: 2022 $127K for 6,003 services; 2023 $121K for 5,496 services; 2024 $124K for 5,384 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victor Czerkasij prescribed most often to Medicare patients was Triamcinolone Acetonide, with 311 prescriptions and refills. In total Victor Czerkasij wrote 1,666 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 311 | 375 | 257 | $3,772 |
| Ketoconazole Generic | 237 | 273 | 138 | $3,019 |
| Dupixent Syringe Dupilumab | 153 | 153 | 17 | $593K |
| Minoxidil Generic | 119 | 261 | 36 | $967 |
| Dupixent Pen Dupilumab | 113 | 116 | 19 | $499K |
| Clobetasol Propionate Generic | 91 | 97 | 66 | $6,599 |
| Metronidazole Generic | 72 | 81 | 62 | $5,360 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 51 | 51 | 44 | $214 |
| Fluorouracil Generic | 41 | 42 | 38 | $3,760 |
| Minocycline Hcl Generic | 36 | 37 | 24 | $716 |
| Spironolactone Generic | 34 | 62 | Under 11 | $527 |
| Clindamycin Phosphate Generic | 31 | 33 | 13 | $1,082 |
| Clindamycin Hcl Generic | 30 | 30 | 28 | $157 |
| Valacyclovir Valacyclovir Hcl | 25 | 25 | 16 | $544 |
| Humira(Cf) Pen Adalimumab | 23 | 23 | Under 11 | $342K |
Brand drugs: 430 claims; generic drugs: 1,236 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor Czerkasij $154K ($154K in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $52K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 62 | $52K |
| Abbvie Inc. ABBV | 31 | $18K |
| Arcutis Biotherapeutics, Inc. ARQT | 44 | $17K |
| Lilly USA, LLC LLY | 36 | $15K |
| UCB, Inc. UCB.BR | 37 | $13K |
| Galderma Laboratories, L.P. GALD.SW | 26 | $11K |
| Regeneron Healthcare Solutions, Inc. REGN | 22 | $7,120 |
| Novartis Pharmaceuticals Corporation NVS | 37 | $6,178 |
| Kowa Pharmaceuticals America, Inc. | 7 | $5,245 |
| Eli Lilly and Company LLY | 5 | $4,033 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.